Brazilian President Jair Bolsonaro has thanked Prime Minister Narendra Modi for allowing the export of raw materials to his country to produce hydroxychroloquine - an anti-malaria drug - seen as useful in the treatment of COVID-19.
"As an outcome of my direct conversation with Indian Prime Minister, we'll receive, raw materials to continue our production of Hydroxychloroquine to treat COVID-19. I thank Prime Minister Narendra Modi and the people of India for such timely help to the people of Brazil," Bolsonaro said in an address to his nation on Wednesday.
Brazil has the highest number of COVID-19 cases in South America with more than 14,000 infections and almost 700 deaths.
Bolsonaro was one of the leaders Prime Minister Modi spoke to over the weekend in his continuing interaction with world leaders since the outbreak of the pandemic. During his conversation, the Brazilian president had put forth his request to Modi to release the ingredients for HCQ that India had placed a ban on.
During the phone call, the two leaders had also stressed the significance of close cooperation between India and Brazil, bilaterally as well as in the multilateral institutional framework, to mitigate the grave crises caused by COVID-19. They agreed on the need to forge a new human-centric concept of globalisation for the post-COVID world.
India is the largest manufacturer of hydroxychloroquine in the world. But the Directorate General of Foreign Trade (DGFT) had banned exports of the drug and its ingredients in view of the rapid rise in the infection-related cases in the country.
On Wednesday, US President Donald Trump thanked PM Modi and the people of India for lifting curbs on the export of hydroxychloroquine.
"Extraordinary times require even closer cooperation between friends. Thank you, India and the Indian people for the decision on HCQ. Will not be forgotten! Thank you Prime Minister @NarendraModi for your strong leadership in helping not just India, but humanity, in this fight!" Trump had said in a post on Twitter on Wednesday.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
